Trial intelligence / Profile preview

Caudal versus transforaminal epidural triamcinolone injection for walking impairment in lumbar spinal stenosis

TCTR20250911004Phase 3Recruiting

Sponsor
Chonburi Hospital
Start
Sep 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triamcinolone, bupivacaine in lumbar spinal stenosis (LSS), sponsored by Chonburi Hospital. Started Sep 2024; status: recruiting.

02

Drugs

triamcinolonebupivacaine
03

Conditions

lumbar spinal stenosis (LSS)

Beyond the preview

Go deeper on TCTR20250911004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250911004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call